We are live on ! Find out more
DALS

DA32 Life Science Tech Acquisition Corp. Class A Common Stock

Delisted

DALS was delisted on the 28th of July, 2023.

0 hedge funds and large institutions have $0 invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 500 (-50)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $177M → $0 (-$177M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 50

Holders
Holders Change
-50
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
50
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FTCM
1
First Trust Capital Management
Illinois
-$24.2M -2,355,502 Closed
DM
2
Deerfield Management
New York
-$16.4M -1,600,000 Closed
BlackRock
3
BlackRock
New York
-$15.4M -1,500,000 Closed
SCM
4
Saba Capital Management
New York
-$12.7M -1,240,593 Closed
PC
5
Periscope Capital
Ontario, Canada
-$12.1M -1,182,558 Closed
MCM
6
Moore Capital Management
New York
-$7.7M -750,000 Closed
Millennium Management
7
Millennium Management
New York
-$7.33M -714,100 Closed
MF
8
Magnetar Financial
Illinois
-$6.73M -655,522 Closed
Citadel Advisors
9
Citadel Advisors
Florida
-$5.99M -584,130 Closed
Janus Henderson Group
10
Janus Henderson Group
United Kingdom
-$4.42M -430,000 Closed
AA
11
AQR Arbitrage
Connecticut
-$4.12M -401,880 Closed
LA
12
Linden Advisors
New York
-$3.91M -381,300 Closed
CF
13
Cantor Fitzgerald
New York
-$3.78M -368,606 Closed
SCM
14
Shaolin Capital Management
Florida
-$3.69M -359,721 Closed
WC
15
Wealthspring Capital
New York
-$3.69M -359,250 Closed
Marshall Wace
16
Marshall Wace
United Kingdom
-$3.29M -320,517 Closed
AC
17
Aristeia Capital
Connecticut
-$3.14M -305,800 Closed
SFM
18
Spartan Fund Management
Canada
-$4.05M -282,680 Closed
WCMNY
19
Westchester Capital Management (New York)
New York
-$2.88M -280,900 Closed
ETH
20
Exos TFP Holdings
New York
-$2.84M -276,688 Closed
HIM
21
HGC Investment Management
Ontario, Canada
-$2.54M -247,920 Closed
AMC
22
Atlas Merchant Capital
New York
-$2.54M -247,193 Closed
SIA
23
Schechter Investment Advisors
Michigan
-$2.34M -227,937 Closed
NIP
24
Nicholas Investment Partners
California
-$2.05M -200,000 Closed
FTCM
25
Fir Tree Capital Management
New York
-$1.78M -173,034 Closed

DALS Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q3 2023, worth a combined $0 — down 100% from $177M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of DALS and 0 opened new positions — a net loss of 50 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was First Trust Capital Management, exiting entirely with an estimated $24.2M sold.

  • 0 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q3 2023, down from 50 in Q2 2023.
  • Funds reported $0 of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q3 2023 and 50 closed out, a net change of -50 holders.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q3 2023 was First Trust Capital Management, an estimated $24.2M sold.

Based on aggregated 13F filings for Q3 2023.